JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (3): 87-92.doi: 10.6040/j.issn.1671-7554.0.2014.844

Previous Articles     Next Articles

Gene detection and analysis for hemophilia B among populations in Shandong Province

LU Min1, CHEN Yun1, DING Botong2, CHANG Yali1, ZHOU Yawei1, ZHAO Aiping3, GUO Nongjian1   

  1. 1. Department of Hematology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China;
    2. Department of Pathology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China;
    3. Hemophilia Treatment Center of Shandong Province, Blood Center of Shandong Province, Jinan 250013, Shandong, China
  • Received:2014-11-18 Revised:2015-02-28 Online:2015-03-10 Published:2015-03-10

PDF (PC)

210

Abstract: Objective To analyze the FIX gene mutation type of hemophilia B among populations in Shandong Province, and to explore the molecular mechanism of this disease. Methods The 8 exons of FIX gene and their flanking sequence of 24 cases of hemophilia B from 19 different families were detected with PCR amplification and direct sequencing. The data obtained were compared with data in the international FIX gene mutations database. Results A total of 18 different types of mutations were detected. Our study first discovered 5 new mutation types, including c.200delA, c.306delT, c.688-690delGGA, c.1025C > G, and c.1157C >A. Conclusion FIX gene mutation is the fundamental cause of hemophilia B, which presents high heterogeneity and dispersibility. This experiment has discovered 5 kinds of new mutations, which not only enrich the FIX gene mutations spectrum, but also provide the molecular basis of the pathogenesis.

Key words: Coagulation factor IX, Gene mutation, Gene sequencing, Hemophilia B

CLC Number: 

  • R574
[1] Giannelli F, Green PM, High KA, et al. Haemophilia B:database of point mutations and short additions and deletions—third edition, 1992[J]. Nucleic Acids Res, 1992, 20(Suppl):2027-2063.
[2] Matrai J, Chuah MK, VandenDriessche T. Preclinical and clinical progress in hemophilia gene therapy[J]. Curr Opin Hematol, 2010, 17(5):387-392.
[3] 王鸿利, 王学锋. 血友病诊断和治疗的专家共识[J]. 内科理论与实践, 2009, 4(3):236-244.
[4] 张之南, 沈悌. 血液病诊断及疗效标准[M]. 3版. 北京:科学出版社, 2007:193-194.
[5] Vidal F, Farssac E, Altisent C, et al. Factor IX gene sequencing by a simple and sensitive 15-hour procedure for haemophilia B diagnosis:identification of two novel mutations[J]. Br J Haematol, 2000, 111(2):549-551.
[6] Anson DS, Choo KH, Rees DJ, et al. The gene structure of human anti-haemophilic factor IX[J]. EMBO J, 1984, 3(5):1053-1060.
[7] Yoshitake S, Schach BG, Foster DC, et al. Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)[J]. Biochemistry, 1985, 24(14):3736-3750.
[8] 张媛, 杨林花, 陆晔玲, 等. 应用DNA测序技术检测血友病B患者FⅨ基因突变[J]. 中国实验血液学杂志, 2009, 17(2):476-478. ZHANG Yuan, YANG Linghua, LU Yeling, et al. Detection of factor IX gene mutation in patients with hemophilia B by DNA sequencing[J]. Journal of Experimental Hematology, 2009, 17(2):476-478.
[9] 张媛, 郭智, 何学鹏. 血友病B的基因诊断[J]. 国际遗传学杂志, 2010 (5):303-305. ZHANG Yuan, GUO Zhi, HE Xuepeng. The gene diagnosis of haemophilia B[J]. International Journal of Genetics, 2010(5):303-305.
[10] DiScipio RG, Davie EW. Characterization of protein S, a gamma.-carboxyglutamic acid containing protein from bovine and human plasma[J]. Biochemistry, 1979, 18(5):899-904.
[11] Zögg T, Brandstetter H. Activation mechanisms of coagulation factor IX[J]. Biol Chem, 2009, 390(5-6):391-400.
[12] Rallapalli PM, Kemball-Cook G, Tuddenham EG, et al. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B[J]. J Thromb Haemost, 2013, 11(7):1329-1340.
[13] Li T, Miller CH, Payne AB, et al. The CDC Hemophilia B mutation project mutation list:a new online resource[J]. Mol Genet Genomic Med, 2013, 1(4):238-245.
[14] Tagariello G, Belvini D, Salviato R, et al. The Italian haemophilia B mutation database:a tool for genetic counselling, carrier detection and prenatal diagnosis[J]. Blood Transfus, 2007, 5(3):158-163.
[15] Hamasaki-Katagiri N, Salari R, Simhadri VL, et al. Analysis of F9 point mutations and their correlation to severity of haemophilia B disease[J]. Haemophilia, 2012, 18(6):933-940.
[16] 张之南, 郝玉书, 赵永强, 等. 血液病学[M]. 2版. 北京:人民卫生出版社, 2012:1313.
[17] Thompson AR, Bajaj SP, Chen SH, et al. “Founder” effect in different families with haemophilia B mutation[J]. Lancet, 1990, 335(8686):418.
[18] Li T, Miller CH, Driggers J, et al. Mutation analysis of a cohort of US patients with hemophilia B[J]. Am J Hematol, 2014, 89(4):375-379.
[19] 王朝荣, 余自强, 孙玲, 等. 40例血友病乙患者的基因分析及发病机制研究[J]. 中国实验血液学杂志, 2013, 21(4):963-968. WANG Chaorong, YU Ziqiang, SUN Ling, et al. Gene analysis and pathogenesis in 40 patients with hemophilia B[J]. Journal of Experimental Hematology, 2013, 21(4):963-968.
[1] HU Sicui, SUN Qing, WANG Yibing, SUN Lili, SUI Yanxi, LI Tang. Analysis of CLCNKB gene mutation in two families with Bartter syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 64-70.
[2] SUN Jin, HAN Bo, WEI Mei-li, YANG Wen-wei, WANG Jie-zhong, LIU Yong-jiao. Mutation screening of TFAP2B gene in children with patent ductus arteriosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 72-75.
[3] SUN Ya-fang1, WANG Yin-chang2, WANG Lai-cheng3, JIAO Yu-lian3, CUI Bin3, XIA Yu3, LU Bing-ru3, ZHAO Yue-ran1,3. Mutation analysis of SQSTM1 and TNFRSF11A genes in
a Chinese family with Paget disease of bone [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(12): 107-113.
[4] XU JIan-min,CHEN Jian,WANG Min,LIU Fu-guo. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1135-1138.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd